Mechanistically, NSUN2-mediated m5C modification suppresses TIAM2 expression through YBX1, and disruption of the NSUN2/TIAM2 axis impairs the EMT, thereby slowing pancreatic cancer progression (Zhang G. et al., 2023). The gene discussed is YBX1; the disease is familial pancreatic carcinoma.